U.S. FDA Authorizes Moderna, Johnson & Johnson COVID-19 Booster Shots

The United States Food and Drug Administration (FDA) has authorized the use of Moderna and Johnson & Johnson COVID-19 booster shots.

The FDA announced on Oct. 20 that a single booster dose of the Moderna COVID-19 vaccine may be administered to people aged 65 years and older, those aged 18 to 64 years at high risk of severe COVID-19, and those aged 18 to 64 years whose jobs put them at high exposure to the virus.

The Moderna booster shot may be administered at least six months after the primary series, FDA said.

The FDA also authorized the use of a single booster dose of Janssen — the COVID-19 vaccine developed by Johnson & Johnson — for individuals aged 18 years and older after at least two months after the single-dose primary regimen.

Additionally, FDA authorized a “mix and match” —  the use of a different brand of vaccine as a booster shot than the one they used for their initial shots.

An advisory committee to the Centers for Disease Control and Prevention (CDC) will meet on Oct. 21 to discuss and make recommendations on the COVID-19 booster shots. Then, CDC Director Rochelle Walensky will release the final guidelines before an official rollout can begin.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.